Heledd Lewis
Biographic Data
| ID | 3801400 |
|---|---|
| NAME | Heledd Lewis |
| GIVEN NAMES | Heledd |
| FAMILY NAME | Lewis |
| SIGNATURE | LEWIS H |
| AFFILIATIONS | Cardiff University |
| ORCID | 0000-0003-4536-3596 |
| VERIFIED | Yes |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 1 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2025 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
A qualitative exploration of the experiences of adults with cystic fibrosis unable to benefit from triple combination therapy
Elexacaftor/Tezacaftor/Ivacaftor (ETI) is a highly effective modulator therapy that has transformed the lives of many people with Cystic Fibrosis (CF). However, limited research has explored the experiences of those not able to benefit from ETI due to genetic factors. Seven adults with CF participated in semi-structured interviews, and data were analysed using Interpretative Phenomenological Analysis (IPA). Four themes emerged: 'feeling forgotten…
No prominent works on this page.
A qualitative exploration of the experiences of adults with cystic fibrosis unable to benefit from triple combination therapy
Elexacaftor/Tezacaftor/Ivacaftor (ETI) is a highly effective modulator therapy that has transformed the lives of many people with Cystic Fibrosis (CF). However, limited research has explored the experiences of those not able to benefit from ETI due to genetic factors. Seven adults with CF participated in semi-structured interviews, and data were analysed using Interpretative Phenomenological Analysis (IPA). Four themes emerged: 'feeling forgotten…
Cystic Fibrosis Research Advances (1 works)